Chronic Kidney Disease and Renal Transplantation 148 development of immunoassays

@inproceedings{Jacobs2012ChronicKD,
  title={Chronic Kidney Disease and Renal Transplantation 148 development of immunoassays},
  author={Leo Jacobs and Alma M. A. Mingels and Marja P. van Dieijen-Visser},
  year={2012}
}
Patients with end-stage renal disease (ESRD) often suffer from cardiovascular complications and comorbidities. For example, 55% of ESRD patients suffer from congestive heart failure (CHF) and cardiovascular diseases account for the majority of deaths among ESRD patients (Herzog, Ma, & Collins, 1998; National Institutes of Health; National Institute of Diabetes and Digestive and Kidney Diseases; Bethesda, 2007). It is, therefore, of great importance to diagnose the underlying cardiac pathologies… CONTINUE READING